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INTRODUCTION
The main route of human Q fever infections is
inhalation of infectious aerosols. The bacterial
agent, Coxiella burnetii, is frequently found
throughout domestic ruminants. Females consti-
tute potential shedders of C. burnetii through
vaginal mucus, faeces and milk. Q fever is also a
common cause of abortion, especially in goats.
Massive load of bacteria is associated with pla-
centas and aborted foetuses. In experimental
conditions, the Coxevac inactivated phase 1
vaccine (CEVA Sante´ Animale, Libourne, France)
was efﬁcient, and dramatically reduced abortion
and excretion of bacteria [1]. The aim of the
present study was to evaluate the Coxevac
vaccination impact on bacterial shedding in goats
affected by Q fever in natural conditions.
METHODS AND RESULTS
A dairy goat herd was selected during a peak of
abortions associated with Q fever. The herd was
then monitored during the next two kidding
seasons by PCR quantiﬁcation of bacteria in
vaginal mucus sampled on the day of delivery.
Between January and April 2005, 72% of
pregnant females aborted (39 ⁄ 54). The peak
extended until the end of summer. The goats
mating in August were categorised according to
previous abortions or normal kidding, parity
numbers and Q fever analyses at ﬁrst vaccination.
The latter consisted of detecting C. burnetii in the
milk, using a real-time quantitative IS1111-PCR
assay, as well as speciﬁc antibodies using a
commercial ELISA (ELISA Cox Ruminant, LSI,
Lissieu, France). Goats were then randomised into
a vaccinated (V) and a control group (NV). At the
ﬁrst kidding season, the vaccine was adminis-
trated to half of the kids and a boost was
performed on adult goats of the V group.
To check that the vaccine was properly admin-
istered, anti-C. burnetii antibodies were measured
3 weeks and 3 months after the vaccine boost.
Using a mixed-effects model, results showed a
signiﬁcant positive effect of vaccination status on
ELISA %OD (adults, p = 0.008; newborns,
p = 0.0003).
The proportions of vaginal samples showing
positive PCR results in vaccinated and non-
vaccinated animals were very close: 87%
(n = 51) and 88% (n = 59), respectively. Thus,
vaccination did not prevent the shedding.
The shedding level was analysed, real-time
PCR results being expressed as semi-quantitative
bacteria numbers per vaginal swab (Fig. 1). The
PCR results were lower in vaccinated than in non-
vaccinated animals. The highest shedding level
(>106 bacteria per vaginal sample) was less
frequent (4% and 13% in vaccinated and non-
vaccinated animals, respectively) whereas the
lowest level (1–200) was more frequent (24%
and 4% in vaccinated and non-vaccinated ani-
mals, respectively) (Fisher’s exact test, p = 0.02).
Primiparous goats responded better to the
vaccine. Indeed, in this category of animals, none
of the vaccinated animals showed the highest
level, whereas none of the non-vaccinated goats
showed the lowest level (Fisher’s exact test,
p = 0.01). No signiﬁcant difference was observed
among goats after the ﬁrst parity.
Respective effects of parity number and vacci-
nation status on PCR level were studied using a
mixed effects model. The dependent variable
was the PCR level and ﬁxed effects were the
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vaccination status, the parity number and the
interaction between these two variables. Individ-
ual and year were treated as nested random
effects. Only PCR-positive results were taken into
account. The most prominent effect on PCR level
was a negative effect, attributed by the model to
vaccination in primiparous animals (coefﬁcient =
)1.05, p = 0.004). Overall, vaccination had nega-
tive effect on PCR levels (coefﬁcient = )0.13) but
this effect was not signiﬁcant (p = 0.45). Finally,
an overall positive effect on PCR level was
attributed to primiparity (coefﬁcient = 0.71,
p = 0.01).
DISCUSSION
Vaccination might have no effect against initially
infected goats. However, this study was not
designed to take into account the initial infectious
status of the goats. Among goats initially selected
for the study, only two adult goats were deﬁned as
both seronegative and non-shedders inmilk. Initial
abortion was not associated with subsequent high-
er PCR level, either in vaccinated animals (Fisher’s
exact test, p = 0.20) or in non-vaccinated goats
(p = 0.54). Half of the kidswere seronegative at the
time of vaccination, all born from infected and non-
vaccinated mothers. Most were selected at 3–
4 months of age when acquiring active immunity.
An infection possibly resulted in an early antibody
response. Five out of eight goats selected at
8 months old were seronegative and all shed
bacteria at the ﬁrst parturition: two when vacci-
nated and three non-vaccinated kids.
In conclusion, the vaccine appeared neither
able to prevent infection in exposed kids, nor to
clear infection in infected goats, but was effective
in reducing massive bacterial shedding from a
heavily infected herd and thus the risk of envi-
ronmental contamination and exposure. Accord-
ing to the present knowledge on C. burnetii
immuno-pathogenesis, cellular immunity could
be enhanced using the vaccine. In particular, T
cells could be the principal actors for clearance of
C. burnetii [2,3]. We observed that the young
population, if not vaccinated, yielded a shedding
level higher than the global level. The infection
resulted in marked shedding among goats of this
age group compared to all studied animals.
Conversely, young vaccinated goats had the
lowest shedding level. The young goats that
appeared most susceptible to both infection and
vaccination. We believe that a potential curative
effect of the vaccine preferentially acted against
early infection.
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Fig. 1. Effect of vaccination on vaginal C. burnetii shedding at the day of kidding for all goats (left) and primiparous goats
(right) subsequently to an outbreak of Q fever abortions. Bacteria numbers per vaginal swab were measured by real-time
PCR and results expressed as semi-quantitative (1–200, 200–104, 104–106 and >106 bacteria per vaginal sample). NV = not
vaccinated, V = vaccinated.
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